オプションチェーンは、Intergroupの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Intergroupの市場センチメントを評価します。.

Intergroup (NASDAQ:INTG) 株価情報, オプションチェーン

The Intergroup

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

The Intergroup Corporation - Common Stock

The Intergroup Corp

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Digital Realty Trust Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>)</h3>
<ul>
<li>On Jan. 27, JMP Securities analyst Greg Miller initiated coverage on Digital Realty Trust with a Market Outperform and announced a $220 price target. The company' stock fell around 9% over the past five days and has a <a href="https://www.benzinga.com/quote/DLR">52-week low of $131.42</a>.</li>
<li>RSI Value: 24.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>DLR Price Action: Shares of Digital Realty Trust fell 8.7% to close at $164.74 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1">DLR news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="817" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041253/image-213.png" alt="" class="wp-image-752954" style="width:536px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041253/image-213.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041253/image-213-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041253/image-213-768x692.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">InterGroup Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTG#NASDAQ">INTG</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>The company's stock fell around 16% over the past five days and <a href="https://www.benzinga.com/quote/INTG">has a 52-week low </a>of $11.81.</li>
<li>RSI Value: 24.5</li>
<li>INTG Price Action: Shares of InterGroup International fell 4.1% to close at $11.86 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1">INTG stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="916" height="821" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041320/image-214.png" alt="" class="wp-image-752955" style="width:499px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041320/image-214.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041320/image-214-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041320/image-214-768x688.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<h3 class="wp-block-heading">Wheeler Real Estate Investment Trust Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WHLR#NASDAQ">WHLR</a>)</h3>
<ul>
<li>On Nov. 15, 2014, Wheeler Real Estate Investment Trust announced a 1-for-2 reverse stock split. The company's stock fell around 47% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/WHLR">low of $1.82</a>.</li>
<li>RSI Value: 25.1</li>
<li>WHLR Price Action: Shares of Wheeler Real Estate Investment Trust jumped 294% to close at $7.84 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1">WHLR share</a>s. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="865" height="821" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041406/image-215.png" alt="" class="wp-image-752958" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041406/image-215.png 865w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041406/image-215-300x285.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/28041406/image-215-768x729.png 768w" sizes="(max-width: 865px) 100vw, 865px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/01/43230206/jim-cramer-is-worried-about-this-consumer-cyclical-stock-7-yield-something-may-be-wrong-here">Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? &#8216;Something May Be Wrong Here&#8217;</a></li>
</ul>

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

INTG

WHLR

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio This Quarter

Shares of Titan Machinery Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/titn#NASDAQ">TITN</a>) moved lower during Thursday&rsquo;s trading following weak quarterly results.
Titan Machinery posted quarterly earnings of $1.32 per share, missing market estimates of $1.53 per share. The company&rsquo;s quarterly sales came in at $694.12 million versus estimates of $727.20 million.
Titan Machinery shares declined 8.1% to $23.41 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Minim Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares jumped 700% to $7.36 after gaining over 13% on Wednesday.</li>
<li>AgriFORCE Growing Systems Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agri#NASDAQ">AGRI</a>) gained 174% to $2.47.</li>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) surged 116% to $0.90 after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Beh&ccedil;et&#39;s disease.</li>
<li>ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imgn#NASDAQ">IMGN</a>) shares jumped 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) gained 46% to $2.2221.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) shares climbed 45% to $5.00.</li>
<li>REX American Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rex#NYSE">REX</a>) gained 30.7% to $48.22 following strong third-quarter results.</li>
<li>Clearmind Medicine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmnd#NASDAQ">CMND</a>) rose 24.2% to $5.03 after surging 22% on Wednesday. Clearmind Medicine recently announced results from its weight loss and metabolic disorder program.</li>
<li>Ucommune International Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uk#NASDAQ">UK</a>) gained 21.8% to $6.58.</li>
<li>Ampio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ampe#NASDAQ">AMPE</a>) shares surged 21% to $2.3750 after gaining over 3% on Wednesday.</li>
<li>Reborn Coffee, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rebn#NASDAQ">REBN</a>) gained 19.5% to $0.6216. Reborn Coffee announced conversion of $1 million of outstanding debt into common equity.</li>
<li>Zuora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zuo#NASDAQ">ZUO</a>) gained 19.5% to $9.98 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>SpringWorks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swtx#NASDAQ">SWTX</a>) climbed 18.3% to $31.75.</li>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) gained 17% to $3.65.</li>
<li>The InterGroup Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intg#NASDAQ">INTG</a>) rose 13.7% to $25.50.</li>
<li>Victoria&#39;s Secret &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) climbed 13.6% to $26.80 following third-quarter results.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) gained 11.7% to $8.44 after gaining around 8% on Wednesday.</li>
<li>Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) rose 11.2% to $1.0842.</li>
<li>Salesforce, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>) shares gained 8.4% to $249.69 after the company reported third-quarter financial results and issued FY24 guidance above estimates.</li>
<li>Oatly Group AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otly#NASDAQ">OTLY</a>) gained 7.5% to $1.0750.</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) climbed 7.1% to $187.76 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Nutanix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntnx#NASDAQ">NTNX</a>) rose 5% to $43.61 after the company reported better-than-expected first-quarter financial results and raised FY24 revenue guidance.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vivos Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vvos#NASDAQ">VVOS</a>) shares fell 40.7% to $24.30. Vivos Therapeutics shares jumped around 832% on Wednesday after the company announced it received FDA 510(k) clearance for treating severe obstructive sleep apnea in adults using the Vivos&#39; removable CARE oral appliances.</li>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) fell 35.6% to $1.8499 after gaining 26% on Wednesday. On Monday, Redhill Biopharma announced that the FDA had granted five years&#39; market exclusivity for its drug, Talicia, on top of three years&#39; exclusivity granted for the approval of Talicia.</li>
<li>POET Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/poet#NASDAQ">POET</a>) fell 31.4% to $0.7603 after the company reported pricing of $1.4 million underwritten public offering of common shares and warrants.</li>
<li>Elevai Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elab#NASDAQ">ELAB</a>) fell 28% to $2.54.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 26.8% to $2.2226.</li>
<li>PROOF Acquisition Corp I (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/paci#NASDAQ">PACI</a>) declined 25% to $24.00.</li>
<li>Lizhi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lizi#NASDAQ">LIZI</a>) fell 21.5% to $2.9750 following third-quarter results.</li>
<li>Gyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gyre#NASDAQ">GYRE</a>) declined 14.6% to $22.45.</li>
<li>Carbon Revolution Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crev#NASDAQ">CREV</a>) fell 14.3% to $33.00.</li>
<li>Pure Storage, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pstg#NYSE">PSTG</a>) fell 14.2% to $32.54 after the company reported worse-than-expected third-quarter revenue results and issued FY24 revenue guidance below estimates.</li>
<li>Nvni Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvni#NASDAQ">NVNI</a>) shares fell 12.2% to $2.03 after gaining over 5% on Wednesday.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arwr#NASDAQ">ARWR</a>) fell 11.8% to $25.55 following FY23 results.</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) declined 11.5% to $10.02 after the company announced a proposed offering of $300 million convertible senior notes and a proposed offering of ADSs in connection with the Delta Placement of Borrowed ADSs.</li>
<li>BRP Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dooo#NASDAQ">DOOO</a>) fell 10.6% to $62.48 following third-quarter results.</li>
<li>Movado Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mov#NYSE">MOV</a>) fell 9.4% to $26.25 following weak sales.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) fell 9.4% to $2.40 after dipping 14% on Wednesday.</li>
<li>Frontline plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fro#NYSE">FRO</a>) shares fell 6.7% to $19.77 following downbeat third-quarter earnings.</li>
<li>Cracker Barrel Old Country Store, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbrl#NASDAQ">CBRL</a>) declined 6.5% to $70.21 following weak results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/11/36016689/how-to-make-500-a-month-with-pfizer-stock"> How To Make $500 A Month With Pfizer Stock</a>

Penny Stocks

Small Cap

Intraday Update

Movers

ADTX

AGRI

AMPE

ARWR

CBRL

CMND

CREV

DOOO

ELAB

FTCH

GYRE

IMGN

JFBR

LIZI

MINM

NTNX

NVNI

OTLY

PACI

POET

PSTG

RDHL

REBN

SMFL

SNGX

SNOW

SWTX

TITN

VSCO

VVOS

XRTX

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Shares of La-Z-Boy Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lzb#NYSE">LZB</a>) moved higher on Thursday as the company reported upbeat earnings results for its second quarter and increased its quarterly <a href="https://www.benzinga.com/quote/LZB/earnings">cash dividend by 10%</a>.
La-Z-Boy posted adjusted earnings of 74 cents per share, beating market estimates of 62 cents per share. The company&rsquo;s quarterly sales came in at $511.44 million versus estimates of $502.33 million.
La-Z-Boy shares gained 7.5% to $34.08 on Thursday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>ImmunoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imgn#NASDAQ">IMGN</a>) shares surged 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash.</li>
<li>REX American Resources Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rex#NYSE">REX</a>) shares rose 30.7% to $48.22 following strong third-quarter results.</li>
<li>Zuora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zuo#NASDAQ">ZUO</a>) climbed 19.5% to $9.98 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>SpringWorks Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swtx#NASDAQ">SWTX</a>) rose 18.3% to $31.75.</li>
<li>The InterGroup Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intg#NASDAQ">INTG</a>) climbed 13.7% to $25.50.</li>
<li>Victoria&#39;s Secret &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vsco#NYSE">VSCO</a>) surged 13.6% to $26.80 following third-quarter results.</li>
<li>VinFast Auto Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vfs#NASDAQ">VFS</a>) rose 11.7% to $8.44 after gaining around 8% on Wednesday.</li>
<li>Farfetch Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ftch#NYSE">FTCH</a>) gained 11.2% to $1.0842.</li>
<li>Bicycle Therapeutics plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcyc#NASDAQ">BCYC</a>) rose 11% to $15.01.</li>
<li>MorphoSys AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mor#NASDAQ">MOR</a>) surged 10.7% to $6.59.</li>
<li>QuinStreet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnst#NASDAQ">QNST</a>) gained 10.4% to $12.67. B. Riley Securities upgraded QuinStreet from Neutral to Buy and raised the price target from $11 to $19.</li>
<li>Salesforce, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crm#NYSE">CRM</a>) shares climbed 8.4% to $249.69 after the company reported third-quarter financial results and issued FY24 guidance above estimates.</li>
<li>EverQuote, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) gained 7.8% to $10.33. B. Riley upgraded EverQuote from Neutral to Buy and raised the price target from $8 to $14.</li>
<li>Petco Health and Wellness Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/woof#NASDAQ">WOOF</a>) rose 7.7% to $2.9397.</li>
<li>Oatly Group AB (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otly#NASDAQ">OTLY</a>) rose 7.5% to $1.0750.</li>
<li>Snowflake Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snow#NYSE">SNOW</a>) surged 7.1% to $187.76 after the company reported better-than-expected third-quarter financial results and issued guidance.</li>
<li>Snap Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/snap#NYSE">SNAP</a>) rose 6.6% to $13.85 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $12 to $16.</li>
<li>PVH Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pvh#NYSE">PVH</a>) gained 6.2% to $97.16 following upbeat earnings.</li>
<li>COMPASS Pathways plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmps#NASDAQ">CMPS</a>) gained 6.2% to $6.30.</li>
<li>Nutanix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntnx#NASDAQ">NTNX</a>) gained 5% to $43.61 after the company reported better-than-expected first-quarter financial results and raised FY24 revenue guidance.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/11/36001417/wall-streets-most-accurate-analysts-say-hold-these-3-tech-stocks-delivering-high-dividend-yields"> Wall Street&#39;s Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields</a>

BCYC

CMPS

EVER

Morgan Stanley Capital Protected Notes for S&P 500 Index

QNST

SNAP

WOOF

La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday

<h3>Gainers</h3>
<ul>
<li>Spruce Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprb#NASDAQ">SPRB</a>) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.</li>
<li>Genfit SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnft#NASDAQ">GNFT</a>) shares climbed 54.2% to close at $5.09 on Friday after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor.</li>
<li>Bellerophon Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blph#NASDAQ">BLPH</a>) climbed 34.6% to close at $3.19 after topline data from Phase 2 study (PULSE-PHPF-002) evaluating the acute hemodynamic benefit of INOpulse via right heart catheterization for pulmonary hypertension associated with sarcoidosis (PH-Sarc).</li>
<li>Ipsidy Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auid#NASDAQ">AUID</a>) jumped 27.3% to close at $16.72.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) surged 26.3% to settle at $17.70. Citigroup recently initiated coverage on Iris Energy with a Buy rating and announced a price target of $18.</li>
<li>Galecto, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glto#NASDAQ">GLTO</a>) gained 22.6% to close at $2.82.</li>
<li>Arqit Quantum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arqq#NASDAQ">ARQQ</a>) rose 22% to settle at $19.92. Arqit Quantum, last week, announced its financial results for the fiscal year ended 30 September.</li>
<li>Crown ElectroKinetics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crkn#NASDAQ">CRKN</a>) jumped 20.8% to settle at $3.37. Crown ElectroKinetics, last month, posted a Q2 loss of $0.39 per share.</li>
<li>Science 37 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snce#NASDAQ">SNCE</a>) rose 20.1% to close at $12.17.</li>
<li>Inozyme Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inzy#NASDAQ">INZY</a>) climbed 19.9% to settle at $7.54.</li>
<li>Net 1 UEPS Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ueps#NASDAQ">UEPS</a>) gained 19.4% to close at $5.05.</li>
<li>Vertical Aerospace Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evtl#NYSE">EVTL</a>) climbed 19.4% to close at $12.84. Vertical Aerospace listed on NYSE following merger with Broadstone Acquisition Corp.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) gained 19.1% to settle at $29.12 following a strong opening box office performance of &#39;Spider-Man: No Way Home.&#39;</li>
<li>Tufin Software Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tufn#NASDAQ">TUFN</a>) rose 18.7% to close at $10.55. The company recently announced the release of the Tufin Security Policy Builder (SPB) App, the latest addition to the Tufin Marketplace.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) gained 18.5% to settle at $18.32.</li>
<li>Roivant Sciences Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roiv#NASDAQ">ROIV</a>) rose 18.3% to close at $10.95.</li>
<li>ForgeRock, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/forg#NYSE">FORG</a>) jumped 17.8% to settle at $25.28. The company recently disclosed two significant new features to the ForgeRock Identity Cloud called Organizations and Themed User Journeys.</li>
<li>cbdMD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ycbd#NYSE">YCBD</a>) rose 17.7% to close at $1.33. cbdMD reported FY21 net sales of $44.5 million versus $41.8 million in FY20.</li>
<li>ORIC Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oric#NASDAQ">ORIC</a>) gained 16.9% to close at $14.98. ORIC Pharma recently highlighted presentation of data supporting therapeutic potential of ORIC-533 in multiple myeloma at American Society of Hematology Meeting.</li>
<li>The InterGroup Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intg#NASDAQ">INTG</a>) rose 16.9% to close at $51.90.</li>
<li>DermTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dmtk#NASDAQ">DMTK</a>) surged 16.5% to settle at $18.89. BioIQ and DermTech recently reported a deal to bring increased patient access to precision genomics.</li>
<li>Dyadic International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dyai#NASDAQ">DYAI</a>) surged 16.2% to settle at $4.59. Dyadic reported research, license, collaboration deal with J&amp;J&#39;s Janssen for manufacture of therapeutic protein candidates using its C1 platform.</li>
<li>Veracyte, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcyt#NASDAQ">VCYT</a>) gained 16.2% to close at $44.99.</li>
<li>POINT Biopharma Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pnt#NASDAQ">PNT</a>) rose 15.9% to settle at $5.60.</li>
<li>AxoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axgn#NASDAQ">AXGN</a>) gained 15.9% to settle at $10.27.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elym#NASDAQ">ELYM</a>) surged 15.4% to close at $10.79.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 15.3% to close at $6.54.</li>
<li>TG Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tgtx#NASDAQ">TGTX</a>) rose 15.3% to settle at $18.24. TG Therapeutics recently announced FDA acceptance of Biologics License Application for Ublituximab as a treatment for patients with relapsing forms of multiple sclerosis.</li>
<li>Clovis Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clvs#NASDAQ">CLVS</a>) gained 15.3% to close at $3.17.</li>
<li>BridgeBio Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbio#NASDAQ">BBIO</a>) rose 15.1% to settle at $42.65.</li>
<li>Bottomline Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/epay#NASDAQ">EPAY</a>) climbed 14.7% to settle at $56.13. Thoma Bravo agreed to acquire financial technology provider Bottomline Technologies in an all-cash transaction valuing Bottomline at $2.6 billion.</li>
<li>Intercept Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icpt#NASDAQ">ICPT</a>) surged 14% to close at $17.14.</li>
<li>Intercept Pharmaceuticals recently announced the withdrawal of an EMA Marketing Authorization Application for obeticholic acid for advanced liver fibrosis due to NASH.</li>
<li>Cerner Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cern#NASDAQ">CERN</a>) gained 12.9% to close at $89.77 following a report from the Wall Street Journal titled &#39;Oracle in Talks to Buy Cerner.&#39;</li>
<li>Teladoc Health, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NYSE">TDOC</a>) climbed 11.8% to close at $97.77.</li>
<li>OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) climbed 10.5% to close at $4.41.</li>
<li>Immix Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/immx#NASDAQ">IMMX</a>) rose 9% to close at $4.00. The company priced its IPO at $5 per share.</li>
<li>FedEx Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fdx#NYSE">FDX</a>) gained 5% to close at $250.32 after the company reported better-than-expected results for its second quarter and boosted its FY22 earnings guidance. The company also reported a $5 billion buyback, including $1.5 billion accelerated buyback program.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Abeona Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abeo#NASDAQ">ABEO</a>) shares fell 40% to close at $0.2930 on Friday after the company reported pricing of public offering of common stock and warrants.</li>
<li>GBS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gbs#NASDAQ">GBS</a>) dropped 23.2% to close at $1.26. GBS recently reported application for FDA breakthrough device designation to fast track rapid saliva glucose test.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) fell 20.2% to settle at $12.95. TeraWulf recently said it has completed previously-announced business combo deal with IKONICS.</li>
<li>Fresh Vine Wine, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vine#NYSE">VINE</a>) shares declined 19.9% to close at $5.73.</li>
<li>Pasithea Therapeutics Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktta#NASDAQ">KTTA</a>) dropped 19.1% to settle at $1.48.</li>
<li>Adagio Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adgi#NASDAQ">ADGI</a>) fell 19% to settle at $11.48 following Jefferies note showing firm research of 2 preprints suggested co.&#39;s ADG20 retains activity against omicron variant.</li>
<li>Cryo-Cell International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccel#NASDAQ">CCEL</a>) fell 18.9% to close at $11.27.</li>
<li>BlackSky Technology Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bksy#NYSE">BKSY</a>) shares dropped 18.8% to settle at $5.72.</li>
<li>Eqonex Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eqos#NASDAQ">EQOS</a>) fell 17.6% to close at $2.02.</li>
<li>Metacrine, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtcr#NASDAQ">MTCR</a>) dropped 17.6% to settle at $1.36.</li>
<li>Nutriband Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntrb#NASDAQ">NTRB</a>) declined 17.3% to settle at $4.11. Nutriband recently received cGMP certification for manufacturing subsidiary.</li>
<li>Stronghold Digital Mining, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdig#NASDAQ">SDIG</a>) fell 16.2% to close at $12.59. Stronghold Digital Mining recently announced better-than-expected Q3 sales results.</li>
<li>Sono-Tek Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sotk#NASDAQ">SOTK</a>) declined 15.1% to settle at $6.82.</li>
<li>IsoPlexis Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iso#NASDAQ">ISO</a>) fell 14.8% to close at $5.13.</li>
<li>Worksport Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wksp#NASDAQ">WKSP</a>) dipped 13.8% to close at $2.75.</li>
<li>Blue Star Foods Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bsfc#NASDAQ">BSFC</a>) fell 12.9% to settle at $2.49. Blue Star Foods recently announced plans to acquire the assets of Gault Seafood, LLC.</li>
<li>Edgewise Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ewtx#NASDAQ">EWTX</a>) dropped 12.7% to settle at $15.50.</li>
<li>Customers Bancorp, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cubi#NYSE">CUBI</a>) dropped 12.4% to close at $57.06.</li>
<li>Qutoutiao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtt#NASDAQ">QTT</a>) fell 11.3% to close at $3.12.</li>
<li>Rivian Automotive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rivn#NASDAQ">RIVN</a>) fell 10.3% to close at $97.70 after the company reported Q3 earnings results and said it expects to be a few hundred vehicles short of its 2021 production target of 1,200 vehicles.</li>
<li>Tyra Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tyra#NASDAQ">TYRA</a>) fell 9% to close at $12.51.</li>
<li>SeaChange International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/seac#NYSE">SEAC</a>) fell 7.8% to close at $1.54. SeaChange International recently reported better-than-expected Q3 results..</li>
<li>ION Geophysical Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/io#NYSE">IO</a>) fell 7.3% to close at $3.12. ION Geophysical, last month, reported Q3 EPS of $0.05.</li>
<li>Kaixin Auto Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kxin#NASDAQ">KXIN</a>) shares fell 7.1% to close at $1.57. Kaixin Auto shares jumped 36% on Thursday after the company announced an agreement with Bujia, which agreed to order at least 10,000 new energy trucks from Kaixin in the next five years.</li>
<li>Expro Group Holdings N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xpro#NYSE">XPRO</a>) fell 6.8% to close at $13.53.</li>
<li>CorEnergy Infrastructure Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/corr#NYSE">CORR</a>) fell 5.4% to close at $3.13. CorEnergy Infr Trust recently reported Q3 sales of $37.03 million.</li>
</ul>

ABEO

ADGI

ARQQ

AUID

AXGN

BBIO

BlackSky Technology Inc. Class A Common Stock

BKSY

BLPH

BSFC

CCEL

CERN

CLVS

CORR

CRKN

CUBI

DMTK

DYAI

ELYM

EPAY

EQOS

EVTL

EWTX

FORG

GLTO

GNFT

IBRX

ICPT

IMMX

INZY

IREN

KTTA

KXIN

MTCR

NTRB

NVTA

ORIC

RIVN

ROIV

SDIG

SEAC

SNCE

SOTK

SPRB

TDOC

TGTX

TUFN

TYRA

UEPS

VCYT

VINE

WKSP

WULF

XPRO

YCBD

63 Biggest Movers From Friday

<h3>Gainers</h3>
<ul>
<li>DLocal Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dlo#NASDAQ">DLO</a>) shares jumped 54.2% to close at $32.39 on Thursday. DLocal raised around $92.6 million from the sale of 4.4 million shares in its IPO.</li>
<li>GTT Communications, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gtt#NYSE">GTT</a>) shares surged 39.6% to close at $3.49 on Thursday on abnormally-high volume. The company&rsquo;s stock also jumped over 57% on Wednesday.</li>
<li>Energy Focus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/efoi#NASDAQ">EFOI</a>) jumped 35.4% to close at $5.81. Energy Focus announced a partnership with threeUV to jointly market and distribute UV By Energy Focus products.</li>
<li>The InterGroup Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/intg#NASDAQ">INTG</a>) surged 30.1% to settle at $51.90.</li>
<li>Community Bankers Trust Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/esxb#NASDAQ">ESXB</a>) shares gained 29.4% to close at $11.90 after United Bankshares announced it will acquire Community Bankers Trust.</li>
<li>Workhorse Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wkhs#NASDAQ">WKHS</a>) surged 28.2% to close at $14.77 as retail trader interest increased as a result of the stock&#39;s high short interest. Workhorse Group shares also surged around 20% on Wednesday.</li>
<li>Conn&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/conn#NASDAQ">CONN</a>) gained 27.3% to settle at $30.57 after the company reported better-than-expected Q1 sales results.</li>
<li>Kindred Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kin#NASDAQ">KIN</a>) climbed 23.7% to settle at $6.73. Kindred Biosciences recently reported results from pivotal efficacy study of parvovirus monoclonal antibody.</li>
<li>PyroGenesis Canada Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyr#NASDAQ">PYR</a>) rose 23.4% to close at $6.34. PyroGenesis reported request for cost estimate from a major iron ore producer for thirty-six plasma torches.</li>
<li>SemiLEDs Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/leds#NASDAQ">LEDS</a>) gained 23.3% to close at $15.10.</li>
<li>Jiuzi Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jzxn#NASDAQ">JZXN</a>) shares gained 20.3% to settle at $11.20. The company, last month, priced its upsized IPO of up to $5.2 million ordinary shares at $5 per share.</li>
<li>Tellurian Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tell#NASDAQ">TELL</a>) jumped 19.2% to close at $5.16 after the company announced it signed a 10-year LNG agreement for 3 mtpa with Vitol.</li>
<li>Xeris Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xers#NASDAQ">XERS</a>) surged 18.8% to settle at $3.85.</li>
<li>EuroDry Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edry#NASDAQ">EDRY</a>) jumped 17.9% to close at $32.89.</li>
<li>Ra Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rmed#NYSE">RMED</a>) gained 16.9% to close at $4.35. Ra Medical, last month, reported better-than-expected Q1 results.</li>
<li>Vertex Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtnr#NASDAQ">VTNR</a>) gained 15.9% to close at $9.39 after declining around 6% on Wednesday.</li>
<li>iPower Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ipw#NASDAQ">IPW</a>) surged 15.1% to settle at $7.25.</li>
<li>Tenneco Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ten#NYSE">TEN</a>) surged 15% to close at $21.13.</li>
<li>Sigma Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sglb#NASDAQ">SGLB</a>) gained 14.8% to settle at $4.27.</li>
<li>Recon Technology, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcon#NASDAQ">RCON</a>) jumped 14.7% to close at $13.68. Recon entered into share exchange agreement with Starry Blockchain Energy.</li>
<li>Sundial Growers Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) rose 14.2% to close at $1.29 amid renewed interest from retail investors.</li>
<li>Castor Maritime Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ctrm#NASDAQ">CTRM</a>) rose 13.1% to close at $3.53 after the company swung to a profit in the first quarter.</li>
<li>Nortech Systems Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nsys#NASDAQ">NSYS</a>) gained 12.8% to settle at $7.22. Nortech Systems announced a Cooperation and Project Funding agreement with Marp&eacute; Technologies and the BIRD Foundation.</li>
<li>Clean Energy Fuels Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clne#NASDAQ">CLNE</a>) rose 12.2% to close at $9.12.</li>
<li>1847 Goedeker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/goed#NYSE">GOED</a>) shares climbed 11.3% to close at $2.56. Sabby recently disclosed a 11% passive stake in 1847 Goedeker.</li>
<li>Vascular Biogenics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vblt#NASDAQ">VBLT</a>) gained 10.5% to close at $2.64 after the company announced a primary endpoint amendment in the OVAL Phase 3 registration-enabling study of VB-111.</li>
<li>Elastic NV (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/estc#NYSE">ESTC</a>) rose 10% to settle at $129.84 after the company reported better-than-expected Q4 results and issued strong sales guidance.</li>
<li>Asensus Surgical, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/asxc#NYSE">ASXC</a>) gained 8.9% to settle at $2.70.</li>
<li>IGM Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/igms#NASDAQ">IGMS</a>) rose 8.7% to close at $87.94. The company highlighted expansion of IgM platform into infectious diseases.</li>
<li>Salarius Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrx#NASDAQ">SLRX</a>) rose 5.3% to close at $1.40 after gaining around 5% on Wednesday.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>PetMed Express, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pets#NASDAQ">PETS</a>) fell 28.3% to close at $33.01 after climbing 58% on Wednesday.</li>
<li>Bed Bath &amp; Beyond Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbby#NASDAQ">BBBY</a>) shares fell 27.8% to settle at $31.90 on Thursday after surging 62% on Wednesday. Bed Bath &amp; Beyond recently announced plans to launch three new Owned Brands this quarter.</li>
<li>Tian Ruixiang Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tirx#NASDAQ">TIRX</a>) shares dipped 24.5% to close at $7.60 on Thursday after the company priced its 4.8 million unit follow-on offering at $7.50 per unit.</li>
<li>Koss Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/koss#NASDAQ">KOSS</a>) dipped 24.3% to settle at $30.83. Koss shares jumped 69% on Wednesday amid retail investor interest in the stock.</li>
<li>Express, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/expr#NYSE">EXPR</a>) fell 19.5% to close at $5.24 after the company announced an at-the-market equity offering for up to 15 million shares.</li>
<li>AMC Entertainment Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) fell 17.9% to settle at $51.34. AMC Entertainment shares soared higher by over 95% on Wednesday amid renewed interest from retail investors. The company announced Tuesday that it raised $230.5 million in new equity from Mudrick Capital.</li>
<li>FireEye Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/feye#NASDAQ">FEYE</a>) shares fell 17.6% to settle at $18.56 after the company announced the sale of FIreEye Products business to Symphony Technology Group for $1.2 billion.</li>
<li>Credit Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cacc#NASDAQ">CACC</a>) fell 16.2% to close at $385.26.</li>
<li>American Superconductor Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amsc#NASDAQ">AMSC</a>) shares declined 15.5% to settle at $12.76 after the company late Wednesday reported Q1 results..</li>
<li>Day One Biopharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dawn#NASDAQ">DAWN</a>) fell 14.3% to close at $19.00. The company recently priced its IPO at $16 per share.</li>
<li>GT Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtbp#NASDAQ">GTBP</a>) fell 14% to settle at $16.31.</li>
<li>InnSuites Hospitality Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iht#NYSE">IHT</a>) dipped 13.8% to close at $7.45.</li>
<li>GSX Techedu Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gotu#NYSE">GOTU</a>) fell 13.8% to settle at $14.95.</li>
<li>Reneo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) declined 13.7% to close at $9.23.</li>
<li>Hovnanian Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hov#NYSE">HOV</a>) dropped 13.6% to close at $118.17 following Q2 results.</li>
<li>CooTek (Cayman) Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctk#NYSE">CTK</a>) shares fell 13.6% to settle at $1.78 as the company reported a first-quarter FY21 revenue decline of 24% year-on-year to $81.6 million, beating the analyst consensus of $80 million.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) dropped 13.5% to close at $10.90.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) tumbled 13.2% to close at $33.27.</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/edu#NYSE">EDU</a>) dipped 12.1% to close at $9.32.</li>
<li>Replimune Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/repl#NASDAQ">REPL</a>) fell 12% to close at $31.90 as the company announced updated data from its Phase 2 skin cancer cohorts combining RP1 with Bristol-Myers Squibb Company&#39;s Opdivo and data from its Phase 1 study of RP2 alone and in combination with Opdivo, that continued to provide strong support for development in its lead indications.</li>
<li>Singular Genomics Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omic#NASDAQ">OMIC</a>) fell 10.4% to close at $27.73. The company recently priced its IPO at $22 a share.</li>
<li>C3.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ai#NYSE">AI</a>) shares fell 10.4% to close at $68.26 after the company reported a loss for its fourth quarter.</li>
<li>Splunk Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/splk#NASDAQ">SPLK</a>) shares dipped 9.5% to settle at $111.98 after the company reported worse-than-expected Q1 EPS results.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) dipped 8.5% to close at $258.18, selling off after the stock saw recent strength amid renewed interest in the name from retail investors on social media forums.</li>
<li>Alpine Income Property Trust Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pine#NYSE">PINE</a>) fell 8.4% to close at $18.05 after the company announced a public offering of 2.5 million shares of common stock.</li>
</ul>

Comments

Intergroup

Intergroup (INTG) オプション

No option chain data available. Please try again later

ニュース

パートナーシップ

ベンジンガ・グローバル